Gerald Kleymann
University of Tubingen, Germany
Biography
Gerald Kleymann has received his PhD from the Max Planck Institute of Biophysics and the University of Frankfurt in 1994. He worked with Bayer Pharmaceuticals as a Lab Head and Coordinator of strategic projects where he discovered the helicase primase inhibitors to treat herpes disease. He was appointed as Apl. Professor at the University of Tübingen in 2009. He has founded diverse companies e.g. the private clinic Primedica, Innovative Molecules and Your Lab. He has published numerous papers, patents, review articles and book chapters.
Abstract
Abstract : Novel agents and strategies to treat herpes simplex virus infections